EFLM connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European “Specialists in Laboratory Medicine”.

EFLM represents IFCC in Europe.

History

The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) was formed in June 2007 at the Euromedlab Congress in Amsterdam by the merger of the Forum of European Societies of Clinical Chemistry (FESCC) and the European Communities Confederation of Clinical Chemistry (EC4).

Who we are

EFLM connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European “Specialists in Laboratory Medicine”. EFLM provides European leadership in Clinical Chemistry and Laboratory Medicine to national professional societies, the diagnostic industry and to governmental and non-governmental organisations in order to serve the public interest in health care. EFLM represents the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) in Europe.

All National Societies in Europe may become members of EFLM. The President/Chair and one national representative of member societies form the General Assembly. This is the main governing body of EFLM. The General Assembly of EFLM convenes at least once every two years. EFLM is legally registered in Belgium and its office is in Milan, maintained in collaboration with IFCC.

Current membership of EFLM comprises the national societies of the following 40 countries: Albania, Austria, Belgium, Bosnia-Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kosovo (provisional member), Latvia, Lithuania, Luxembourg, Macedonia, Montenegro, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Turkey, Ukraine and United Kingdom.

The operational structure of EFLM consists of an Executive Board (EB) and five Committees (C) which carry out their tasks via Working Groups (WG). Officers of the EB (president, past-president, president elect, secretary, treasurer and two members-at-large) are elected by the General Assembly for 2-year terms. Membership in Cs and WGs is by application and open to nominations by national societies when a call for nominations is issued.

The official scientific journal of EFLM is Clinical Chemistry and Laboratory Medicine (CCLM).

Vision and Mission

Clinical Chemistry and Laboratory Medicine is at the heart of modern healthcare, and plays a vital role in screening for disease, diagnosis, risk assessment, treatment selection, monitoring of therapy, prognosis and other aspects of clinical decision-making. It is thus central to effective patient care. Patients throughout Europe have the right to expect high standards of Laboratory Medicine wherever they present to the health care system.

The mission of EFLM is to enhance patient care and improve outcomes by promoting and improving the scientific, professional and clinical aspects of clinical chemistry and laboratory medicine and to ensure effective representation of laboratory medicine both at European Union level and to other pan-European and sub-regional bodies. EFLM deals with specific European issues of Clinical Chemistry and Laboratory Medicine.

What we do

The main activities of EFLM relate to education, research, development of the profession, requirements for competence, quality and accreditation of laboratories, organisation of congresses, and publications. EFLM has five Committees:

  • Communications (C-C)
  • Education and Training (C-ET)
  • Profession (C-P)
  • Quality and Regulations (C-QR)
  • Science (C-S)

Communications Committee

The Communications Committee is responsible for communicating EFLM’s activities and results to its membership, related partner organizations and the public via EFLM’s website and Newsletter.
The Committee has one Working Group "Promotion" and a Task and Finish Group "EFLM History".

Education and Training Committee

The Education and Training Committee has general responsibility for the postgraduate training aspects of the work of EFLM in the field of Clinical Chemistry and Laboratory Medicine focused on laboratory medicine professionals, health care professionals and patients, in liaison with the Education and Management Division of IFCC, and also with UEMS (European Union of Medical Specialists).
In liaison with the IFCC Congresses and Conferences Committee, the C-ET Committee works on the bid preparation, evaluation of the applications to host the EuroMedLab Congresses. In collaboration with UEMS-SLM, the Committee works on the bid preparation and applicants evaluation to host the EFLM-UEMS Congresses. Such evaluated bid material is presented to the General Assemblies for final decision.
The Committee organizes regional and sub-regional conferences, workshops and postgraduate continuing education courses in association with relevant national societies.
The Committee operates two Working Groups:

  • “Congresses and Postgraduate Education” which is involved in the organization of EFLM’s regional congress, EuroMedLab, in collaboration with IFCC; joint European conferences with UEMS, national societies and sub-regional organizations, such as the annual EFLM Symposium for the Balkan region. It is also responsible for organizing the annual EFLM Continuous Postgraduate Course in Dubrovnik on specific clinical topics and the biannual EFLM Conference on Preanalytical Phase (in collaboration with Becton Dickinson).
    This WG is also involved in creating the Guidelines for all EFLM related scientific and educational events and educational materials as Course handbooks, Conference proceedings and CD with ppt. Presentations which are available on the EFLM web site (www.efcclm.eu)
  • “Distance education and e-learning” which is involved in the organization of distance education programmes and e-learning courses. This WG critically evaluates information from courses, lectures and documents including electronic learning tools. It also interacts with national societies to collect their needs and any potential e-learning resources already available.

Profession Committee

The Profession Committee is responsible for matters of professional regulation and certification (via the EC4 Register of European Specialists in Clinical Chemistry and in Laboratory Medicine), and the promotion of the profession in Europe at government level, and to patients and clinical users. It liaises with CEPLIS (European Council of the Liberal Professions) and with the European Commission and Parliament on professional matters. It takes the lead in developing pan-European professional and ethical standards. It also liaises with UEMS (European Union of Medical Specialists) on the roles and responsibilities of medical and scientific practitioners of the discipline.

Quality and Regulations

The Quality and Regulations Committee supports the establishment of effective accreditation schemes and quality management systems in all European countries and liaises with ISO, CEN and the European Accreditation body (EA).
The Committee currently has one Working Group:

  • “Accreditation and ISO/CEN” which represents EFLM in EA, ISO TC212 and CEN TC140. The WG focuses on influencing ISO/CEN standards and harmonization of accreditation by international surveys, education and training of assessors related to specific professional standards of ISO 15189 and on setting European procedures for accreditation according to the flexible scope.

Science Committee

The Science Committee focuses on promotion of research that translates the scientific results of laboratory medicine to clinical applications and improves patient outcomes through the appropriate use and interpretation of laboratory data in clinical practice.

The Committee currently has the following Working Groups:

  • Biological Variation (WG-BV) which explores the sources of variation in and develops a critical appraisal checklist for papers on biological variation.
  • Cardiac Markers (WG-CM) which investigates, via European surveys, how the reporting, interpretation and use of cardiac markers impact on patient outcomes in different countries.
  • Guidelines (WG-G) for the laboratory investigation and management of various conditions based on best practice.
  • Harmonisation of Total Testing Process (WG-H) which aims to act as a collector of the harmonization initiatives arising from other WGs or Task and Finish Groups of EFLM and from National Member Societies active in the field and will disseminate them to all the EFLM Member Societies attempting to monitor their application and effects.
  • Patient Focused Laboratory Medicine (WG-PFLM) which aims to evaluate and study methods for how specialists in laboratory medicine can communicate directly with the patients and how the laboratory can play an active role in patients using self-monitoring for monitoring their disease.
  • Personalized Laboratory Medicine (WG-PLM) which aims to develop papers on potentials and limits of the most recent laboratory technologies applied in personalized medicine.
  • Postanalytical Phase (WG-POST) which carries out international surveys amongst general practitioners and investigates how doctors use and interpret laboratory tests commonly used for managing patients in primary care.
  • Preanalytical Phase (WG-PRE) which aims to promote the importance of the quality of the preanalytical phase of laboratory medicine by carrying questionnaires for assessing the current practices related to some pre-analytical variables and defining the best practices for some critical activities in the preanalytical phase.
  • Test Evaluation (WG-TE) which sets standards and develops practical tools for designing research studies for the evaluation of the clinical value and impact of new biomarkers.